Hale
Baltimore, US · Founded 2019 · Delaware corporation · 1 known investors
Nicotine addiction treatment through automatic, gradual substance weaning
Founders & leadership
TS
Taha ShipchandlerDirector
CA
Chip AndrewsDirector
PB
Patrick ByrneExecutive Officer, Director
CA
Clayton AndrewsExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$675KraisedFeb 2020 · 13 investors · OtherRule 506(b)
▶$675KraisedFeb 2020 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Taha ShipchandlerDirector
- Chip AndrewsDirector
- Patrick ByrneExecutive Officer, Director
- Clayton AndrewsExecutive Officer, Director
- Offering amount
- $998.5K
- Amount sold
- $675K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.